Samuel Refetoff to MAP Kinase Kinase Kinase 1
This is a "connection" page, showing publications Samuel Refetoff has written about MAP Kinase Kinase Kinase 1.
Connection Strength
0.032
-
Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression. Endocr Relat Cancer. 2014 Oct; 21(5):755-67.
Score: 0.032
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.